Cargando…

Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism

Both pulsatile gonadotropin-releasing hormone (GnRH) infusion and combined gonadotropin therapy (human chorionic gonadotropin and human menopausal gonadotropin [HCG/HMG]) are effective to induce spermatogenesis in male patients with congenital hypogonadotropic hypogonadism (CHH). However, evidence i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Jiang-Feng, Liu, Zhao-Xiang, Nie, Min, Wang, Xi, Xu, Hong-Li, Huang, Bing-Kun, Zheng, Jun-Jie, Min, Le, Kaiser, Ursula Brigitte, Wu, Xue-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676428/ https://www.ncbi.nlm.nih.gov/pubmed/28051040 http://dx.doi.org/10.4103/1008-682X.193568

Ejemplares similares

The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men
por: Zhang, Luyao, et al.
Publicado: (2018)

Spermatogenesis of Male Patients with Congenital Hypogonadotropic Hypogonadism Receiving Pulsatile Gonadotropin-Releasing Hormone Therapy Versus Gonadotropin Therapy: A Systematic Review and Meta-Analysis
por: Wei, Chao, et al.
Publicado: (2021)

Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study
por: Hao, Ming, et al.
Publicado: (2021)

The initiation and maintenance of gonadotropin-releasing hormone neuron identity in congenital hypogonadotropic hypogonadism
por: Chung, Wilson CJ, et al.
Publicado: (2023)

Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism
por: Fanis, Pavlos, et al.
Publicado: (2023)

Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients
por: Hao, Ming, et al.
Publicado: (2019)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

AB029. The beneficial effects of pulsatile gonadotropin-releasing hormone pumps in the treatment of adult male idiopathic hypogonadotropic hypogonadism
por: Li, Yan-Feng, et al.
Publicado: (2018)

MON-LB051 Non-inferiority Clinical Trial on Gonadotropinversus Pulsatile Gonadotropin-releasing Hormone Infusion Therapy in Male Adolescent Patient with Congenital Hypogonadotropic Hypogonadism
por: Liu, Ying
Publicado: (2019)

Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism
por: Ortac, Mazhar, et al.
Publicado: (2019)

Management Outcomes in Males With Hypogonadotropic Hypogonadism Treated With Gonadotropins
por: Sahib, Bahaa O, et al.
Publicado: (2023)

ODP400 A Mutation in the Gonadotropin Releasing Hormone Receptor Associated with Congenital Hypogonadotropic Hypogonadism with Absence of Uterus and Ovaries
por: Alabi, Omolabake, et al.
Publicado: (2022)

Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients
por: Liu, Zhaoxiang, et al.
Publicado: (2016)

Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism
por: Mao, Jiang-Feng, et al.
Publicado: (2018)

Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols
por: Sato, Naoko, et al.
Publicado: (2015)

Growth and descent of the testes in infants with hypogonadotropic hypogonadism receiving subcutaneous gonadotropin infusion
por: Lambert, Anne-Sophie, et al.
Publicado: (2016)

Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases
por: Gürbüz, Ali Sami, et al.
Publicado: (2020)

Induction of spermatogenesis in men with hypogonadotropic hypogonadism
por: Morris, Guy C., et al.
Publicado: (2021)

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
por: Chen, Yin-Wei, et al.
Publicado: (2019)

MON-273 Retrospective Analysis of Gonadotropin-Mediated Pubertal Induction in Male Patients with Congenital Hypogonadotropic Hypogonadism (CHH)
por: Cangiano, Biagio, et al.
Publicado: (2020)

Clinical Characteristics and Spermatogenesis in Patients with Congenital Hypogonadotropic Hypogonadism Caused by FGFR1 Mutations
por: Li, Shuying, et al.
Publicado: (2020)

SUN-092 Effect of Pubertal Induction with Gonadotropins and GnRH Therapy in Male Hypogonadotropic Hypogonadism: Meta-Analysis
por: Agarwal, Swashti, et al.
Publicado: (2020)

Progress and Challenges in the Search for the Mechanisms of Pulsatile Gonadotropin-Releasing Hormone Secretion
por: Constantin, Stephanie
Publicado: (2017)

Pulsatile gonadotropin-releasing hormone: clinical applications of a physiologic paradigm
por: Filicori, Marco
Publicado: (2023)

Predictors of reproductive and non-reproductive outcomes of gonadotropin mediated pubertal induction in male patients with congenital hypogonadotropic hypogonadism (CHH)
por: Cangiano, B., et al.
Publicado: (2021)

Gonadotropin-Induced Spermatogenesis in CHH Patients with Cryptorchidism
por: Liu, Zhaoxiang, et al.
Publicado: (2019)

Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism
por: Lin, Jianli, et al.
Publicado: (2019)

Gonadotropin-Releasing Hormone Agonist Therapy and Obesity in Girls
por: Shiasi Arani, Kobra, et al.
Publicado: (2015)

Evaluating the Combination of Human Chorionic Gonadotropin and Clomiphene Citrate in Treatment of Male Hypogonadotropic Hypogonadism: A Prospective Study
por: Trinh, The Son, et al.
Publicado: (2021)

The diagnostic value of the olfactory evaluation for congenital hypogonadotropic hypogonadism
por: Yu, Bingqing, et al.
Publicado: (2022)

Application of Human Menopausal Gonadotropins in the Treatment of Idiopathic Hypogonadotropic Hypogonadism (IHH)-Based Infertility in Females: A Case Report
por: Ma, Ying-Jie, et al.
Publicado: (2023)

Psychological Aspects of Congenital Hypogonadotropic Hypogonadism
por: Dwyer, Andrew A., et al.
Publicado: (2019)

Congenital hypogonadotropic hypogonadism complicated by neuroblastoma
por: Ueta, Yukiko, et al.
Publicado: (2022)

Beyond hormone replacement: quality of life in women with congenital hypogonadotropic hypogonadism
por: Dzemaili, Shota, et al.
Publicado: (2017)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Development of the gonadotropin‐releasing hormone system
por: Duittoz, Anne H., et al.
Publicado: (2022)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
por: Asakawa, Jumpei, et al.
Publicado: (2018)

Reproductive responses of dairy cows with ovarian cysts to simultaneous human chorionic gonadotropin or gonadotropin-releasing hormone and cloprostenol compared to gonadotropin-releasing hormone alone treatment
por: Taktaz, T., et al.
Publicado: (2015)

Treatment of congenital hypogonadotropic hypogonadism in male patients
por: Lee, Hae Sang, et al.
Publicado: (2022)

The availability of gonadotropin therapy from FDA-approved pharmacies for men with hypogonadism and infertility
por: Borgert, Benjamin J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3903rmr8npof673gr0lejvuht1